New DNA-Based Assay Rapidly Detects E. coli O157:H7 During Food Manufacture
By LabMedica International staff writers Posted on 18 Nov 2015 |
A rapid DNA-based test for the detection of the serious food borne pathogen E. coli O157:H7 joins a line of innovative assays designed for use by the food industry.
The ANSR E. coli O157:H7 kit is a welcome addition to Neogen Corporation’s (Lansing, MI, USA) ANSR tests for Salmonella, Listeria, and Listeria monocytogenes.
Neogen's ANSR (Amplified Nucleic Single Temperature Reaction) platform incorporates advances in DNA detection technology resulting in a method that is easy to use and provides much faster results than PCR systems. ANSR was designed to address in-plant testing needs and offers the freedom to economically process samples to meet regulatory requirements and ensure food safety.
ANSR uses isothermal amplification to create a level of molecular target material that can be detected using fluorescence. The system's DNA amplification methodology exponentially amplifies the DNA of any target bacteria present in an enriched food sample to detectable levels in only minutes. Target nucleic acid is amplified through a mechanism of polymerization from the ends of nicks created in double-stranded DNA by the action of a specific endonuclease. Amplified target sequences are detected in real time using fluorescent molecular beacon probes.
To date, the assay has been validated for testing raw ground beef, raw beef trim, leafy greens, and sprout irrigation water. The system has exhibited low matrix effects with high sensitivity and provides both positive and negative results in minutes.
"The well-received and validated ANSR system provides the food industry definitive test results, and much easier and quicker methodology," said Ed Bradley, vice president of food safety at Neogen. "This introduction of ANSR for E. coli O157:H7 extends our ANSR product offering for the bacterial pathogens of greatest concern to the food industry, and will be very easy for laboratories to adopt, as it follows the same procedure of all our other ANSR kits."
Related Links:
Neogen Corporation
The ANSR E. coli O157:H7 kit is a welcome addition to Neogen Corporation’s (Lansing, MI, USA) ANSR tests for Salmonella, Listeria, and Listeria monocytogenes.
Neogen's ANSR (Amplified Nucleic Single Temperature Reaction) platform incorporates advances in DNA detection technology resulting in a method that is easy to use and provides much faster results than PCR systems. ANSR was designed to address in-plant testing needs and offers the freedom to economically process samples to meet regulatory requirements and ensure food safety.
ANSR uses isothermal amplification to create a level of molecular target material that can be detected using fluorescence. The system's DNA amplification methodology exponentially amplifies the DNA of any target bacteria present in an enriched food sample to detectable levels in only minutes. Target nucleic acid is amplified through a mechanism of polymerization from the ends of nicks created in double-stranded DNA by the action of a specific endonuclease. Amplified target sequences are detected in real time using fluorescent molecular beacon probes.
To date, the assay has been validated for testing raw ground beef, raw beef trim, leafy greens, and sprout irrigation water. The system has exhibited low matrix effects with high sensitivity and provides both positive and negative results in minutes.
"The well-received and validated ANSR system provides the food industry definitive test results, and much easier and quicker methodology," said Ed Bradley, vice president of food safety at Neogen. "This introduction of ANSR for E. coli O157:H7 extends our ANSR product offering for the bacterial pathogens of greatest concern to the food industry, and will be very easy for laboratories to adopt, as it follows the same procedure of all our other ANSR kits."
Related Links:
Neogen Corporation
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples